Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Adient Q3 2024 Sales $3.716B Miss $3.826B Estimate

Author: Benzinga Newsdesk | August 06, 2024 06:53am

Adient (NYSE:ADNT) reported quarterly sales of $3.716 billion which missed the analyst consensus estimate of $3.826 billion by 2.87 percent. This is a 8.36 percent decrease over sales of $4.055 billion the same period last year.

Posted In: ADNT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist